Tag: IIT-Bhubaneswar
-
ILS and IIT-Bhubaneswar Pioneer Next-Generation TB Subunit Vaccine Hsp16.3C4
Breakthrough in TB Research: A New Subunit Vaccine In a landmark collaboration, the Institute of Life Sciences (ILS) in Bhubaneswar and IIT-Bhubaneswar have announced the development of a next-generation subunit vaccine for tuberculosis (TB). The vaccine, named Hsp16.3C4, represents a significant step forward in the global effort to curb TB, which remains a major public…
-
Groundbreaking TB Vaccine Collaboration: IIT-Bhubaneswar and ILS Unveil Hsp16.3C4
Overview of the Breakthrough In a landmark collaboration, the Institute of Life Sciences (ILS), Bhubaneswar, and the Indian Institute of Technology Bhubaneswar (IIT-Bhubaneswar) announced the development of a next-generation subunit tuberculosis (TB) vaccine named Hsp16.3C4. The joint effort aims to address persistent challenges in TB prevention, including vaccine efficacy, stability, and scalability in diverse populations.…
-
ILS and IIT-Bhubaneswar Announce Breakthrough TB Vaccine Hsp16.3C4
Significant Collaboration Advances TB Prevention The Institute of Life Sciences (ILS) in Bhubaneswar has joined forces with IIT-Bhubaneswar to unveil a next-generation subunit vaccine aimed at tuberculosis (TB). The vaccine, named Hsp16.3C4, represents a pivotal step in the ongoing global effort to curb TB through vaccination, offering potential advantages in safety, stability, and ease of…